Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.27291522 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.93303271 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.93303271 |
4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.59808254 |
5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.21410233 |
6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.17674798 |
7 | negative thymic T cell selection (GO:0045060) | 5.12532606 |
8 | negative T cell selection (GO:0043383) | 5.10545994 |
9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.76109042 |
10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.76109042 |
11 | modulation by symbiont of host immune response (GO:0052553) | 4.76109042 |
12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.76109042 |
13 | modulation by symbiont of host defense response (GO:0052031) | 4.76109042 |
14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.76109042 |
15 | regulation of gamma-delta T cell activation (GO:0046643) | 4.69833764 |
16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.41214849 |
17 | positive thymic T cell selection (GO:0045059) | 4.40133053 |
18 | positive regulation of B cell differentiation (GO:0045579) | 4.30617654 |
19 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.28242082 |
20 | macrophage activation involved in immune response (GO:0002281) | 4.22029861 |
21 | B cell receptor signaling pathway (GO:0050853) | 4.21844865 |
22 | neutrophil activation involved in immune response (GO:0002283) | 4.20161315 |
23 | detection of other organism (GO:0098543) | 4.17263747 |
24 | thymic T cell selection (GO:0045061) | 4.16323451 |
25 | detection of bacterium (GO:0016045) | 4.14581952 |
26 | regulation of B cell differentiation (GO:0045577) | 4.13399914 |
27 | leukocyte aggregation (GO:0070486) | 4.05018447 |
28 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.02796502 |
29 | T cell selection (GO:0045058) | 3.98685021 |
30 | ribosomal small subunit assembly (GO:0000028) | 3.90324612 |
31 | negative regulation of phagocytosis (GO:0050765) | 3.89994244 |
32 | negative regulation of interleukin-12 production (GO:0032695) | 3.88964009 |
33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.88056821 |
34 | response to peptidoglycan (GO:0032494) | 3.80782723 |
35 | positive T cell selection (GO:0043368) | 3.74477645 |
36 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.73445523 |
37 | negative regulation of cell killing (GO:0031342) | 3.73445523 |
38 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.73440913 |
39 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.65322195 |
40 | response to interleukin-15 (GO:0070672) | 3.59257335 |
41 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.47777236 |
42 | detection of external biotic stimulus (GO:0098581) | 3.46913793 |
43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.46284885 |
44 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.46190668 |
45 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.43410514 |
46 | negative regulation of T cell mediated immunity (GO:0002710) | 3.41707420 |
47 | positive regulation of lamellipodium assembly (GO:0010592) | 3.36417744 |
48 | myeloid cell activation involved in immune response (GO:0002275) | 3.32059741 |
49 | response to muramyl dipeptide (GO:0032495) | 3.31207546 |
50 | sequestering of actin monomers (GO:0042989) | 3.30960264 |
51 | T cell receptor signaling pathway (GO:0050852) | 3.30160632 |
52 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.29409915 |
53 | cellular response to zinc ion (GO:0071294) | 3.29020454 |
54 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.26045185 |
55 | response to host immune response (GO:0052572) | 3.26045185 |
56 | barbed-end actin filament capping (GO:0051016) | 3.25461184 |
57 | germinal center formation (GO:0002467) | 3.25049721 |
58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.25038379 |
59 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.21213760 |
60 | T cell costimulation (GO:0031295) | 3.19626109 |
61 | DNA deamination (GO:0045006) | 3.18793538 |
62 | natural killer cell differentiation (GO:0001779) | 3.16349338 |
63 | T cell migration (GO:0072678) | 3.16174200 |
64 | T cell apoptotic process (GO:0070231) | 3.15091625 |
65 | regulation of mast cell degranulation (GO:0043304) | 3.14956451 |
66 | cellular response to interleukin-15 (GO:0071350) | 3.14641336 |
67 | lymphocyte costimulation (GO:0031294) | 3.14389942 |
68 | respiratory burst (GO:0045730) | 3.12306336 |
69 | neutrophil activation (GO:0042119) | 3.12126605 |
70 | cellular response to virus (GO:0098586) | 3.10738997 |
71 | regulation of antigen processing and presentation (GO:0002577) | 3.09708168 |
72 | modulation by virus of host process (GO:0019054) | 3.08415068 |
73 | negative regulation of innate immune response (GO:0045824) | 3.08140228 |
74 | viral transcription (GO:0019083) | 3.07866412 |
75 | hepatocyte apoptotic process (GO:0097284) | 3.06381398 |
76 | cellular extravasation (GO:0045123) | 3.06222765 |
77 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.04229767 |
78 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.03987384 |
79 | response to host (GO:0075136) | 3.03987384 |
80 | response to host defenses (GO:0052200) | 3.03987384 |
81 | NIK/NF-kappaB signaling (GO:0038061) | 3.03046443 |
82 | granulocyte activation (GO:0036230) | 3.02999433 |
83 | interferon-gamma production (GO:0032609) | 3.02868244 |
84 | positive regulation of antigen processing and presentation (GO:0002579) | 3.01430627 |
85 | tolerance induction (GO:0002507) | 3.00937224 |
86 | detection of molecule of bacterial origin (GO:0032490) | 3.00592584 |
87 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.00421139 |
88 | actin nucleation (GO:0045010) | 3.00287797 |
89 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.99176997 |
90 | regulation of T cell tolerance induction (GO:0002664) | 2.99049023 |
91 | detection of biotic stimulus (GO:0009595) | 2.98452421 |
92 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.97510363 |
93 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.96941783 |
94 | T cell homeostasis (GO:0043029) | 2.96513812 |
95 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.94885923 |
96 | regulation of tolerance induction (GO:0002643) | 2.94730873 |
97 | regulation of leukocyte degranulation (GO:0043300) | 2.93165472 |
98 | positive regulation of lamellipodium organization (GO:1902745) | 2.92464931 |
99 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.91996190 |
100 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.91137353 |
101 | immunoglobulin mediated immune response (GO:0016064) | 2.90947877 |
102 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.90087477 |
103 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.88468020 |
104 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.88468020 |
105 | DNA unwinding involved in DNA replication (GO:0006268) | 2.87828622 |
106 | translational termination (GO:0006415) | 2.86857316 |
107 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.86767766 |
108 | regulation of response to interferon-gamma (GO:0060330) | 2.86654804 |
109 | microglial cell activation (GO:0001774) | 2.86137092 |
110 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.84418849 |
111 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.84395507 |
112 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.83441103 |
113 | leukocyte degranulation (GO:0043299) | 2.82320893 |
114 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.81738517 |
115 | macrophage activation (GO:0042116) | 2.81305790 |
116 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.80852344 |
117 | mature B cell differentiation involved in immune response (GO:0002313) | 2.80089564 |
118 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.79612670 |
119 | Peyers patch development (GO:0048541) | 2.79612670 |
120 | lymphocyte apoptotic process (GO:0070227) | 2.79068674 |
121 | negative regulation of type 2 immune response (GO:0002829) | 2.78960584 |
122 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.76810862 |
123 | modulation by symbiont of host cellular process (GO:0044068) | 2.74295591 |
124 | B cell mediated immunity (GO:0019724) | 2.73487724 |
125 | regulation of defense response to virus by virus (GO:0050690) | 2.73425675 |
126 | negative regulation of interleukin-6 production (GO:0032715) | 2.73141910 |
127 | positive regulation of interferon-alpha production (GO:0032727) | 2.71532985 |
128 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.70866722 |
129 | translational elongation (GO:0006414) | 2.70721632 |
130 | positive regulation of mast cell activation (GO:0033005) | 2.70406632 |
131 | mast cell activation (GO:0045576) | 2.70000955 |
132 | positive regulation of interleukin-2 production (GO:0032743) | 2.69637964 |
133 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.68793198 |
134 | mature B cell differentiation (GO:0002335) | 2.67326476 |
135 | positive regulation of isotype switching (GO:0045830) | 2.67192676 |
136 | lymphocyte homeostasis (GO:0002260) | 2.67098455 |
137 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.62236118 |
138 | leukocyte cell-cell adhesion (GO:0007159) | 2.61388863 |
139 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.60320424 |
140 | angiogenesis involved in wound healing (GO:0060055) | 2.59893804 |
141 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.59650400 |
142 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.57263983 |
143 | lymph node development (GO:0048535) | 2.57168038 |
144 | response to type I interferon (GO:0034340) | 2.55920218 |
145 | activation of MAPKKK activity (GO:0000185) | 2.54239909 |
146 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.52792164 |
147 | defense response to protozoan (GO:0042832) | 2.52729936 |
148 | myeloid dendritic cell activation (GO:0001773) | 2.52392287 |
149 | natural killer cell activation (GO:0030101) | 2.52079317 |
150 | cellular response to type I interferon (GO:0071357) | 2.51354446 |
151 | type I interferon signaling pathway (GO:0060337) | 2.51354446 |
152 | response to protozoan (GO:0001562) | 2.51249880 |
153 | DNA strand elongation (GO:0022616) | 2.49028839 |
154 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.47272322 |
155 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.45130581 |
156 | positive regulation of T cell differentiation (GO:0045582) | 2.41842113 |
157 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.41668766 |
158 | leukocyte homeostasis (GO:0001776) | 2.41421819 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.96699368 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.71630731 |
3 | * MYC_22102868_ChIP-Seq_BL_Human | 3.69403387 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.43358414 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.27304500 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.22404268 |
7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.98623517 |
8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.98135768 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.80024212 |
10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.74061322 |
11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.68333343 |
12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.50392868 |
13 | MAF_26560356_Chip-Seq_TH1_Human | 2.34669138 |
14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.31062092 |
15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26151888 |
16 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.25648602 |
17 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.18905384 |
18 | MYB_26560356_Chip-Seq_TH2_Human | 2.14226905 |
19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.07547910 |
20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.07499591 |
21 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03798559 |
22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.02404998 |
23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.98851749 |
24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.96943435 |
25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94700672 |
26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.94403787 |
27 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.93831741 |
28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.93766685 |
29 | MYB_26560356_Chip-Seq_TH1_Human | 1.92510851 |
30 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.89974014 |
31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.87674839 |
32 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.85458907 |
33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.82704584 |
34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.80475118 |
35 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.79690159 |
36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.75518603 |
37 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.74852928 |
38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.73475729 |
39 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71232829 |
40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.70774392 |
41 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.68447619 |
42 | MAF_26560356_Chip-Seq_TH2_Human | 1.67514717 |
43 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.66085573 |
44 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.65767239 |
45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64979358 |
46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.64481617 |
47 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62587694 |
48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.62118844 |
49 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61236607 |
50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60853669 |
51 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.57228932 |
52 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56478421 |
53 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50879560 |
54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.48776331 |
55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45481992 |
56 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.44707830 |
57 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.43491943 |
58 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.42770694 |
59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.42235117 |
60 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.40204390 |
61 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39448560 |
62 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.38419324 |
63 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.37395569 |
64 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.37089481 |
65 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36970640 |
66 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.36919154 |
67 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.36341846 |
68 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.35469784 |
69 | P68_20966046_ChIP-Seq_HELA_Human | 1.35316417 |
70 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34466785 |
71 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.34226685 |
72 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.33388983 |
73 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32856967 |
74 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.30875434 |
75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30867530 |
76 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.30764100 |
77 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.28151130 |
78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25133473 |
79 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24590535 |
80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.24467566 |
81 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.23518450 |
82 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.21457865 |
83 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19209444 |
84 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18310987 |
85 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.18039469 |
86 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.17272845 |
87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15646331 |
88 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15053341 |
89 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14928874 |
90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.14652746 |
91 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.14167686 |
92 | KDM2B_26808549_Chip-Seq_K562_Human | 1.13866007 |
93 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.13518494 |
94 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.13164851 |
95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12019051 |
96 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.11934519 |
97 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.11900191 |
98 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.10393132 |
99 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09628397 |
100 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.09350399 |
101 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09040761 |
102 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08868355 |
103 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07204502 |
104 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07117672 |
105 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06834673 |
106 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06771477 |
107 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.06387396 |
108 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05930132 |
109 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.05906636 |
110 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.05835693 |
111 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.04254150 |
112 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03950037 |
113 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03162796 |
114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02351729 |
115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02270172 |
116 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.01121109 |
117 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01044546 |
118 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.00896130 |
119 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.99868442 |
120 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98911855 |
121 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.98076345 |
122 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97905626 |
123 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.97678095 |
124 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.97573720 |
125 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96808698 |
126 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96598978 |
127 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.96185554 |
128 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.94829587 |
129 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93516337 |
130 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.93393954 |
131 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92981733 |
132 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.92215895 |
133 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92008558 |
134 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91886497 |
135 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.90866415 |
136 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.89979388 |
137 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.89680553 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003763_abnormal_thymus_physiology | 3.87440532 |
2 | MP0001835_abnormal_antigen_presentation | 3.78137936 |
3 | MP0000685_abnormal_immune_system | 3.63943101 |
4 | MP0005671_abnormal_response_to | 3.18282527 |
5 | MP0001800_abnormal_humoral_immune | 3.11775190 |
6 | MP0002396_abnormal_hematopoietic_system | 2.94993901 |
7 | MP0002398_abnormal_bone_marrow | 2.78944403 |
8 | MP0005387_immune_system_phenotype | 2.78450289 |
9 | MP0001790_abnormal_immune_system | 2.78450289 |
10 | MP0002452_abnormal_antigen_presenting | 2.68587269 |
11 | MP0009785_altered_susceptibility_to | 2.64883771 |
12 | MP0002420_abnormal_adaptive_immunity | 2.64878792 |
13 | MP0001819_abnormal_immune_cell | 2.61280554 |
14 | MP0005000_abnormal_immune_tolerance | 2.54166919 |
15 | MP0002723_abnormal_immune_serum | 2.52422490 |
16 | MP0009333_abnormal_splenocyte_physiolog | 2.47855684 |
17 | MP0002166_altered_tumor_susceptibility | 2.44775377 |
18 | MP0003436_decreased_susceptibility_to | 2.44280709 |
19 | MP0000716_abnormal_immune_system | 2.37052298 |
20 | MP0000689_abnormal_spleen_morphology | 2.31523762 |
21 | MP0004808_abnormal_hematopoietic_stem | 2.29026376 |
22 | MP0005025_abnormal_response_to | 2.27040309 |
23 | MP0002722_abnormal_immune_system | 2.25196357 |
24 | MP0010352_gastrointestinal_tract_polyps | 2.24061217 |
25 | MP0000703_abnormal_thymus_morphology | 2.23452151 |
26 | MP0002429_abnormal_blood_cell | 2.09337290 |
27 | MP0002405_respiratory_system_inflammati | 2.07924817 |
28 | MP0005464_abnormal_platelet_physiology | 2.02787590 |
29 | MP0003303_peritoneal_inflammation | 1.99519600 |
30 | MP0005397_hematopoietic_system_phenotyp | 1.95713490 |
31 | MP0001545_abnormal_hematopoietic_system | 1.95713490 |
32 | MP0003693_abnormal_embryo_hatching | 1.93858790 |
33 | MP0002419_abnormal_innate_immunity | 1.89723412 |
34 | MP0008260_abnormal_autophagy | 1.89423736 |
35 | MP0010155_abnormal_intestine_physiology | 1.85912196 |
36 | MP0002148_abnormal_hypersensitivity_rea | 1.85395467 |
37 | MP0005451_abnormal_body_composition | 1.82495679 |
38 | MP0002006_tumorigenesis | 1.81109083 |
39 | MP0003300_gastrointestinal_ulcer | 1.78640974 |
40 | MP0001853_heart_inflammation | 1.65292881 |
41 | MP0009278_abnormal_bone_marrow | 1.64108433 |
42 | MP0003075_altered_response_to | 1.62790803 |
43 | MP0004947_skin_inflammation | 1.61139364 |
44 | MP0003866_abnormal_defecation | 1.59224857 |
45 | MP0001873_stomach_inflammation | 1.55020655 |
46 | MP0001845_abnormal_inflammatory_respons | 1.53772311 |
47 | MP0000858_altered_metastatic_potential | 1.52675025 |
48 | MP0002933_joint_inflammation | 1.52021160 |
49 | MP0006054_spinal_hemorrhage | 1.46585526 |
50 | MP0002019_abnormal_tumor_incidence | 1.45092993 |
51 | MP0000490_abnormal_crypts_of | 1.44560925 |
52 | MP0003077_abnormal_cell_cycle | 1.40634979 |
53 | MP0003279_aneurysm | 1.39356642 |
54 | MP0000465_gastrointestinal_hemorrhage | 1.38066913 |
55 | MP0003724_increased_susceptibility_to | 1.37062619 |
56 | MP0010094_abnormal_chromosome_stability | 1.33792271 |
57 | MP0006082_CNS_inflammation | 1.33512912 |
58 | MP0000604_amyloidosis | 1.32673651 |
59 | MP0004957_abnormal_blastocyst_morpholog | 1.28169346 |
60 | MP0008007_abnormal_cellular_replicative | 1.25838385 |
61 | MP0005023_abnormal_wound_healing | 1.24163706 |
62 | MP0004510_myositis | 1.22015322 |
63 | MP0003183_abnormal_peptide_metabolism | 1.20405807 |
64 | MP0003111_abnormal_nucleus_morphology | 1.20101530 |
65 | MP0001533_abnormal_skeleton_physiology | 1.19641151 |
66 | MP0003566_abnormal_cell_adhesion | 1.18833717 |
67 | MP0003828_pulmonary_edema | 1.17629241 |
68 | MP0003806_abnormal_nucleotide_metabolis | 1.10870844 |
69 | MP0004381_abnormal_hair_follicle | 1.09614084 |
70 | MP0003690_abnormal_glial_cell | 1.09338663 |
71 | MP0008469_abnormal_protein_level | 1.05248991 |
72 | MP0003705_abnormal_hypodermis_morpholog | 0.99493934 |
73 | MP0001348_abnormal_lacrimal_gland | 0.99198003 |
74 | MP0001663_abnormal_digestive_system | 0.99089743 |
75 | MP0003329_amyloid_beta_deposits | 0.98002063 |
76 | MP0005076_abnormal_cell_differentiation | 0.95825670 |
77 | MP0000313_abnormal_cell_death | 0.93837545 |
78 | MP0008874_decreased_physiological_sensi | 0.91150866 |
79 | MP0009840_abnormal_foam_cell | 0.90285394 |
80 | MP0004883_abnormal_blood_vessel | 0.89299940 |
81 | MP0000350_abnormal_cell_proliferation | 0.87622455 |
82 | MP0005174_abnormal_tail_pigmentation | 0.87191741 |
83 | MP0003448_altered_tumor_morphology | 0.85023305 |
84 | MP0008058_abnormal_DNA_repair | 0.82931585 |
85 | MP0000343_altered_response_to | 0.82909435 |
86 | MP0005310_abnormal_salivary_gland | 0.82203960 |
87 | MP0003191_abnormal_cellular_cholesterol | 0.82166457 |
88 | MP0004130_abnormal_muscle_cell | 0.79075194 |
89 | MP0000015_abnormal_ear_pigmentation | 0.78966962 |
90 | MP0010307_abnormal_tumor_latency | 0.77626517 |
91 | MP0003045_fibrosis | 0.75663519 |
92 | MP0002132_abnormal_respiratory_system | 0.73416310 |
93 | MP0003172_abnormal_lysosome_physiology | 0.72907276 |
94 | MP0005164_abnormal_response_to | 0.72852699 |
95 | MP0008004_abnormal_stomach_pH | 0.72550943 |
96 | MP0000477_abnormal_intestine_morphology | 0.70725397 |
97 | * MP0001730_embryonic_growth_arrest | 0.69035793 |
98 | MP0002095_abnormal_skin_pigmentation | 0.69027965 |
99 | MP0005058_abnormal_lysosome_morphology | 0.68608053 |
100 | MP0002277_abnormal_respiratory_mucosa | 0.68497016 |
101 | MP0003091_abnormal_cell_migration | 0.67135551 |
102 | MP0009764_decreased_sensitivity_to | 0.66898232 |
103 | MP0004858_abnormal_nervous_system | 0.66751161 |
104 | MP0005075_abnormal_melanosome_morpholog | 0.64467739 |
105 | MP0003656_abnormal_erythrocyte_physiolo | 0.64303342 |
106 | MP0009765_abnormal_xenobiotic_induced | 0.63489742 |
107 | MP0009763_increased_sensitivity_to | 0.62667406 |
108 | MP0000920_abnormal_myelination | 0.62597730 |
109 | MP0000598_abnormal_liver_morphology | 0.62099424 |
110 | MP0004185_abnormal_adipocyte_glucose | 0.61554297 |
111 | MP0003943_abnormal_hepatobiliary_system | 0.60912225 |
112 | MP0005381_digestive/alimentary_phenotyp | 0.59916315 |
113 | * MP0005621_abnormal_cell_physiology | 0.59671559 |
114 | MP0002138_abnormal_hepatobiliary_system | 0.59361976 |
115 | MP0003453_abnormal_keratinocyte_physiol | 0.59265318 |
116 | MP0002332_abnormal_exercise_endurance | 0.59108922 |
117 | * MP0002080_prenatal_lethality | 0.58919124 |
118 | MP0000249_abnormal_blood_vessel | 0.57766293 |
119 | MP0002998_abnormal_bone_remodeling | 0.56492800 |
120 | MP0003879_abnormal_hair_cell | 0.54962780 |
121 | MP0005166_decreased_susceptibility_to | 0.53323676 |
122 | MP0008961_abnormal_basal_metabolism | 0.53300596 |
123 | MP0003795_abnormal_bone_structure | 0.53088660 |
124 | MP0005167_abnormal_blood-brain_barrier | 0.52445410 |
125 | MP0005390_skeleton_phenotype | 0.51444741 |
126 | MP0001542_abnormal_bone_strength | 0.50238554 |
127 | MP0010234_abnormal_vibrissa_follicle | 0.50051626 |
128 | MP0001851_eye_inflammation | 0.49816680 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent bronchitis (HP:0002837) | 4.81367472 |
2 | Abnormality of macrophages (HP:0004311) | 4.61422352 |
3 | Orchitis (HP:0100796) | 4.33302503 |
4 | T lymphocytopenia (HP:0005403) | 4.20998585 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.19662570 |
6 | Chronic otitis media (HP:0000389) | 4.17814496 |
7 | Panhypogammaglobulinemia (HP:0003139) | 4.17299222 |
8 | Agammaglobulinemia (HP:0004432) | 4.14979350 |
9 | Abnormality of T cell number (HP:0011839) | 4.10594249 |
10 | IgM deficiency (HP:0002850) | 3.99463606 |
11 | Recurrent viral infections (HP:0004429) | 3.97397398 |
12 | Retrobulbar optic neuritis (HP:0100654) | 3.96076693 |
13 | Optic neuritis (HP:0100653) | 3.96076693 |
14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.93063179 |
15 | Cellulitis (HP:0100658) | 3.78865816 |
16 | Abnormality of T cells (HP:0002843) | 3.74422151 |
17 | Recurrent fungal infections (HP:0002841) | 3.58012994 |
18 | Abnormality of B cell number (HP:0010975) | 3.51685993 |
19 | B lymphocytopenia (HP:0010976) | 3.51685993 |
20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.46768982 |
21 | Thrombocytosis (HP:0001894) | 3.46702327 |
22 | Gastrointestinal infarctions (HP:0005244) | 3.44829231 |
23 | Papilloma (HP:0012740) | 3.35531636 |
24 | Verrucae (HP:0200043) | 3.35531636 |
25 | Autoimmune thrombocytopenia (HP:0001973) | 3.21499904 |
26 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.20078352 |
27 | Abnormality of glycolipid metabolism (HP:0010969) | 3.20078352 |
28 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.20078352 |
29 | Lymphopenia (HP:0001888) | 3.19330558 |
30 | Nasal polyposis (HP:0100582) | 3.18596606 |
31 | Recurrent abscess formation (HP:0002722) | 3.18341380 |
32 | Eczematoid dermatitis (HP:0000976) | 3.18245461 |
33 | Severe combined immunodeficiency (HP:0004430) | 3.15438806 |
34 | Meningitis (HP:0001287) | 3.14708128 |
35 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.14379641 |
36 | Combined immunodeficiency (HP:0005387) | 3.13268737 |
37 | Abnormality of the nasal mucosa (HP:0000433) | 3.10571298 |
38 | Spontaneous hematomas (HP:0007420) | 3.10345700 |
39 | Myositis (HP:0100614) | 3.09372205 |
40 | IgG deficiency (HP:0004315) | 3.06554984 |
41 | Gastrointestinal inflammation (HP:0004386) | 3.06505612 |
42 | Thyroiditis (HP:0100646) | 3.05654298 |
43 | Abnormality of T cell physiology (HP:0011840) | 2.99570462 |
44 | Gingivitis (HP:0000230) | 2.98357674 |
45 | Urticaria (HP:0001025) | 2.94784863 |
46 | Keratoconjunctivitis sicca (HP:0001097) | 2.94176451 |
47 | Inflammation of the large intestine (HP:0002037) | 2.92433504 |
48 | Chronic sinusitis (HP:0011109) | 2.82761585 |
49 | Dysostosis multiplex (HP:0000943) | 2.74712812 |
50 | Recurrent cutaneous fungal infections (HP:0011370) | 2.74534771 |
51 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.74534771 |
52 | Recurrent bacterial skin infections (HP:0005406) | 2.71577322 |
53 | Colitis (HP:0002583) | 2.67195668 |
54 | Increased cerebral lipofuscin (HP:0011813) | 2.67029359 |
55 | Gastrointestinal stroma tumor (HP:0100723) | 2.66898476 |
56 | Keratoconjunctivitis (HP:0001096) | 2.65971249 |
57 | Increased density of long bones (HP:0006392) | 2.62186726 |
58 | Pustule (HP:0200039) | 2.59385939 |
59 | Eosinophilia (HP:0001880) | 2.58653399 |
60 | Purpura (HP:0000979) | 2.58492224 |
61 | Emphysema (HP:0002097) | 2.57522494 |
62 | Bronchitis (HP:0012387) | 2.54275565 |
63 | Recurrent sinusitis (HP:0011108) | 2.51534304 |
64 | Vasculitis (HP:0002633) | 2.51285829 |
65 | Gingival bleeding (HP:0000225) | 2.47895023 |
66 | Mediastinal lymphadenopathy (HP:0100721) | 2.46528222 |
67 | Basal cell carcinoma (HP:0002671) | 2.43671946 |
68 | Granulocytopenia (HP:0001913) | 2.43348810 |
69 | Lymphoma (HP:0002665) | 2.42572163 |
70 | Abnormality of the fingertips (HP:0001211) | 2.38800652 |
71 | Hypoplasia of the thymus (HP:0000778) | 2.38239063 |
72 | Recurrent skin infections (HP:0001581) | 2.38056932 |
73 | Leukocytosis (HP:0001974) | 2.38056886 |
74 | Episodic fever (HP:0001954) | 2.36218736 |
75 | Abnormality of eosinophils (HP:0001879) | 2.35750993 |
76 | Systemic lupus erythematosus (HP:0002725) | 2.35423423 |
77 | Hypochromic anemia (HP:0001931) | 2.32244352 |
78 | Loss of speech (HP:0002371) | 2.31717503 |
79 | Petechiae (HP:0000967) | 2.30215867 |
80 | Amyloidosis (HP:0011034) | 2.28074585 |
81 | Hypertensive crisis (HP:0100735) | 2.27824718 |
82 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.27800328 |
83 | IgA deficiency (HP:0002720) | 2.27358358 |
84 | Hematochezia (HP:0002573) | 2.27255992 |
85 | Increased serum ferritin (HP:0003281) | 2.23608596 |
86 | Epistaxis (HP:0000421) | 2.20388104 |
87 | Osteomyelitis (HP:0002754) | 2.20128426 |
88 | Viral hepatitis (HP:0006562) | 2.18780588 |
89 | Pulmonary embolism (HP:0002204) | 2.17591356 |
90 | Prolonged bleeding time (HP:0003010) | 2.15299099 |
91 | Peritonitis (HP:0002586) | 2.13832652 |
92 | Slow saccadic eye movements (HP:0000514) | 2.11647504 |
93 | Aplastic anemia (HP:0001915) | 2.08544010 |
94 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.06222859 |
95 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.06222859 |
96 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.06222859 |
97 | Stomatitis (HP:0010280) | 2.05703133 |
98 | Papilledema (HP:0001085) | 2.04482732 |
99 | Hepatosplenomegaly (HP:0001433) | 2.04363019 |
100 | Abnormality of the peritoneum (HP:0002585) | 2.04070882 |
101 | Aortic aneurysm (HP:0004942) | 2.03483230 |
102 | Multiple enchondromatosis (HP:0005701) | 2.02789002 |
103 | Cerebral aneurysm (HP:0004944) | 2.02731699 |
104 | Hypochromic microcytic anemia (HP:0004840) | 2.01971727 |
105 | Protrusio acetabuli (HP:0003179) | 2.01862560 |
106 | Sepsis (HP:0100806) | 1.99620548 |
107 | Vertebral arch anomaly (HP:0008438) | 1.98846870 |
108 | Abnormality of the pleura (HP:0002103) | 1.97858376 |
109 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.97399233 |
110 | Anorexia (HP:0002039) | 1.96276508 |
111 | Hypergammaglobulinemia (HP:0010702) | 1.96261318 |
112 | Interstitial pulmonary disease (HP:0006530) | 1.94735700 |
113 | Supranuclear gaze palsy (HP:0000605) | 1.93449524 |
114 | Chest pain (HP:0100749) | 1.91817814 |
115 | Acne (HP:0001061) | 1.91639841 |
116 | Polygenic inheritance (HP:0010982) | 1.91627317 |
117 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.91403902 |
118 | Skin ulcer (HP:0200042) | 1.91088655 |
119 | Mucopolysacchariduria (HP:0008155) | 1.90688069 |
120 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90688069 |
121 | Autoimmune hemolytic anemia (HP:0001890) | 1.90637395 |
122 | Abnormality of iron homeostasis (HP:0011031) | 1.90293911 |
123 | Recurrent lower respiratory tract infections (HP:0002783) | 1.89471545 |
124 | Increased IgE level (HP:0003212) | 1.87543803 |
125 | Hyperacusis (HP:0010780) | 1.86337607 |
126 | Poikiloderma (HP:0001029) | 1.85442405 |
127 | Restrictive lung disease (HP:0002091) | 1.84201881 |
128 | Encephalitis (HP:0002383) | 1.83462848 |
129 | Recurrent otitis media (HP:0000403) | 1.82151178 |
130 | Abnormal number of erythroid precursors (HP:0012131) | 1.81005693 |
131 | Bicuspid aortic valve (HP:0001647) | 1.80390337 |
132 | Vertebral compression fractures (HP:0002953) | 1.79000952 |
133 | Cutaneous melanoma (HP:0012056) | 1.78685864 |
134 | Dilatation of the ascending aorta (HP:0005111) | 1.76569940 |
135 | Chronic obstructive pulmonary disease (HP:0006510) | 1.76382069 |
136 | Obstructive lung disease (HP:0006536) | 1.76382069 |
137 | Pulmonary infiltrates (HP:0002113) | 1.75167560 |
138 | Arterial thrombosis (HP:0004420) | 1.75042837 |
139 | Subacute progressive viral hepatitis (HP:0006572) | 1.75002336 |
140 | Hemoptysis (HP:0002105) | 1.74494848 |
141 | Increased IgM level (HP:0003496) | 1.73094774 |
142 | Chronic diarrhea (HP:0002028) | 1.72364308 |
143 | Periodontitis (HP:0000704) | 1.71664802 |
144 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.71340257 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.98752072 |
2 | PRPF4B | 3.36313221 |
3 | TRIB3 | 3.08777683 |
4 | MAP3K10 | 2.78792531 |
5 | PKN2 | 2.63735278 |
6 | ZAP70 | 2.53706425 |
7 | EEF2K | 2.44739622 |
8 | ERN1 | 2.27671558 |
9 | PIM2 | 2.22594623 |
10 | GRK6 | 2.16327718 |
11 | JAK3 | 2.15522956 |
12 | MAP2K3 | 2.10468268 |
13 | BTK | 2.05807792 |
14 | TXK | 2.03534770 |
15 | RIPK1 | 1.94890476 |
16 | STK10 | 1.91021432 |
17 | NME2 | 1.90427578 |
18 | TBK1 | 1.88636772 |
19 | TAOK3 | 1.80983760 |
20 | TYK2 | 1.76633277 |
21 | KDR | 1.74340209 |
22 | ITK | 1.72644145 |
23 | BLK | 1.68685803 |
24 | LRRK2 | 1.67207523 |
25 | SYK | 1.62875452 |
26 | FLT3 | 1.61553791 |
27 | TEC | 1.60919282 |
28 | TAOK1 | 1.56294629 |
29 | RPS6KA4 | 1.54991377 |
30 | MAP3K11 | 1.52343482 |
31 | IKBKE | 1.51946642 |
32 | TESK2 | 1.50596743 |
33 | ARAF | 1.49863647 |
34 | KIT | 1.49856777 |
35 | SIK3 | 1.44626087 |
36 | IRAK3 | 1.40104791 |
37 | CSF1R | 1.39454430 |
38 | EPHB1 | 1.34608717 |
39 | SCYL2 | 1.31178729 |
40 | HCK | 1.31029932 |
41 | PIM1 | 1.26588753 |
42 | MAP3K1 | 1.22239283 |
43 | LCK | 1.20564631 |
44 | MARK2 | 1.13831849 |
45 | SMG1 | 1.13483872 |
46 | SIK1 | 1.12771414 |
47 | FGFR4 | 1.11689226 |
48 | FGR | 1.10608820 |
49 | NLK | 1.07562127 |
50 | CSK | 1.04537650 |
51 | KSR2 | 1.03041214 |
52 | PRKD2 | 1.02830233 |
53 | IRAK4 | 1.00876843 |
54 | NEK2 | 0.99625253 |
55 | MAP3K14 | 0.97489897 |
56 | IKBKB | 0.97114668 |
57 | MARK3 | 0.92407043 |
58 | JAK1 | 0.91982817 |
59 | MAP3K13 | 0.91488043 |
60 | TGFBR2 | 0.86846389 |
61 | RAF1 | 0.86615362 |
62 | FES | 0.86193813 |
63 | LYN | 0.84726056 |
64 | CDC42BPA | 0.80940304 |
65 | MAPK12 | 0.80795807 |
66 | TAOK2 | 0.76569936 |
67 | FGFR3 | 0.76036626 |
68 | CDK4 | 0.76026644 |
69 | NEK9 | 0.75981261 |
70 | TESK1 | 0.75899840 |
71 | CLK1 | 0.74874014 |
72 | PDPK1 | 0.74564896 |
73 | PRKCH | 0.73328901 |
74 | MAP3K8 | 0.73113498 |
75 | EIF2AK1 | 0.72705268 |
76 | IRAK2 | 0.72171654 |
77 | DAPK2 | 0.71305484 |
78 | SIK2 | 0.69908808 |
79 | TNK2 | 0.68433144 |
80 | CDK19 | 0.65682661 |
81 | PAK6 | 0.65679789 |
82 | TGFBR1 | 0.65554641 |
83 | CDC7 | 0.64217802 |
84 | MAP3K3 | 0.63698480 |
85 | RPS6KB2 | 0.62325578 |
86 | PTK6 | 0.60548194 |
87 | TTN | 0.57685963 |
88 | GRK7 | 0.55890835 |
89 | ILK | 0.54827768 |
90 | FYN | 0.54566308 |
91 | PAK4 | 0.53489855 |
92 | MAP2K2 | 0.52087266 |
93 | MOS | 0.51922907 |
94 | BUB1 | 0.51891315 |
95 | MAPK7 | 0.51185097 |
96 | MAP3K12 | 0.50430882 |
97 | STK4 | 0.50219321 |
98 | DYRK1B | 0.49267999 |
99 | PRKCQ | 0.47884017 |
100 | CAMKK2 | 0.47536813 |
101 | STK38 | 0.47476109 |
102 | MAPK11 | 0.47401714 |
103 | RPS6KL1 | 0.47243011 |
104 | RPS6KC1 | 0.47243011 |
105 | ICK | 0.47031073 |
106 | JAK2 | 0.46932603 |
107 | CAMKK1 | 0.46155583 |
108 | CHUK | 0.45680822 |
109 | PASK | 0.45664386 |
110 | STK24 | 0.44281412 |
111 | RIPK4 | 0.43037525 |
112 | MAPK4 | 0.42454717 |
113 | BMPR2 | 0.42219763 |
114 | BMX | 0.42095323 |
115 | MAPKAPK3 | 0.41664976 |
116 | ALK | 0.41059842 |
117 | RPS6KA6 | 0.40596238 |
118 | EIF2AK3 | 0.40123411 |
119 | MAP2K6 | 0.38898949 |
120 | MATK | 0.37872268 |
121 | TLK1 | 0.37655940 |
122 | IRAK1 | 0.37634125 |
123 | MAPKAPK2 | 0.37482988 |
124 | WEE1 | 0.37478131 |
125 | DAPK1 | 0.36909148 |
126 | PIK3CG | 0.36705513 |
127 | BRAF | 0.35340914 |
128 | HIPK2 | 0.34287700 |
129 | BRSK1 | 0.33802787 |
130 | ATR | 0.33624190 |
131 | PDK1 | 0.33558719 |
132 | MAP3K5 | 0.32569620 |
133 | MAP3K7 | 0.32418889 |
134 | CDK12 | 0.32233295 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.41123218 |
2 | DNA replication_Homo sapiens_hsa03030 | 2.72540789 |
3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.57556848 |
4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.38556326 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.10336852 |
6 | Base excision repair_Homo sapiens_hsa03410 | 2.07420657 |
7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.05038872 |
8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.99479982 |
9 | Mismatch repair_Homo sapiens_hsa03430 | 1.95585780 |
10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.94620673 |
11 | Measles_Homo sapiens_hsa05162 | 1.93473281 |
12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.92346641 |
13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.84321950 |
14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.78935820 |
15 | Ribosome_Homo sapiens_hsa03010 | 1.75276037 |
16 | Shigellosis_Homo sapiens_hsa05131 | 1.72326263 |
17 | Asthma_Homo sapiens_hsa05310 | 1.69732170 |
18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.68022759 |
19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.62660384 |
20 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.60085176 |
21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.59907157 |
22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.54925159 |
23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53438823 |
24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.53142960 |
25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49192867 |
26 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.47590206 |
27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.42629039 |
28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.39392885 |
29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37429968 |
30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.36175525 |
31 | Apoptosis_Homo sapiens_hsa04210 | 1.35783595 |
32 | Hepatitis B_Homo sapiens_hsa05161 | 1.34480195 |
33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32265409 |
34 | Spliceosome_Homo sapiens_hsa03040 | 1.29925089 |
35 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.27083953 |
36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24453055 |
37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22365443 |
38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.21855728 |
39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.21236644 |
40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20866023 |
41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.19504285 |
42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18588910 |
43 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.17342476 |
44 | Phagosome_Homo sapiens_hsa04145 | 1.17046492 |
45 | HTLV-I infection_Homo sapiens_hsa05166 | 1.16561842 |
46 | Lysosome_Homo sapiens_hsa04142 | 1.16026027 |
47 | Influenza A_Homo sapiens_hsa05164 | 1.15292875 |
48 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.14660070 |
49 | Allograft rejection_Homo sapiens_hsa05330 | 1.14486443 |
50 | Platelet activation_Homo sapiens_hsa04611 | 1.13190679 |
51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.12172297 |
52 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12017645 |
53 | Colorectal cancer_Homo sapiens_hsa05210 | 1.12011458 |
54 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.07702777 |
55 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.05937245 |
56 | Cell cycle_Homo sapiens_hsa04110 | 1.05842010 |
57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03911966 |
58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.03629007 |
59 | Homologous recombination_Homo sapiens_hsa03440 | 1.03176043 |
60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02456083 |
61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00716754 |
62 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00476063 |
63 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.99680318 |
64 | Legionellosis_Homo sapiens_hsa05134 | 0.98594628 |
65 | Proteasome_Homo sapiens_hsa03050 | 0.95612323 |
66 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.94467154 |
67 | Tuberculosis_Homo sapiens_hsa05152 | 0.93397711 |
68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91694879 |
69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87878838 |
70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85478814 |
71 | RNA transport_Homo sapiens_hsa03013 | 0.84785431 |
72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.83260771 |
73 | Salmonella infection_Homo sapiens_hsa05132 | 0.83200191 |
74 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.82752916 |
75 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.82580036 |
76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.82502585 |
77 | Pertussis_Homo sapiens_hsa05133 | 0.81938986 |
78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81580194 |
79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80605046 |
80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.80335704 |
81 | Hepatitis C_Homo sapiens_hsa05160 | 0.80155716 |
82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79026862 |
83 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.78271291 |
84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77644021 |
85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76500353 |
86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71989419 |
87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70094512 |
88 | RNA degradation_Homo sapiens_hsa03018 | 0.69556493 |
89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64224845 |
90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63358890 |
91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62425939 |
92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61587911 |
93 | RNA polymerase_Homo sapiens_hsa03020 | 0.60727379 |
94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58843172 |
95 | Prion diseases_Homo sapiens_hsa05020 | 0.57529240 |
96 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.54762861 |
97 | Malaria_Homo sapiens_hsa05144 | 0.54171843 |
98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.53508192 |
99 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.53406908 |
100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52772028 |
101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52601206 |
102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52126699 |
103 | Endocytosis_Homo sapiens_hsa04144 | 0.51001466 |
104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50842853 |
105 | Amoebiasis_Homo sapiens_hsa05146 | 0.50262902 |
106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50004579 |
107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49330303 |
108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49076791 |
109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48713405 |
110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48576395 |
111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48285684 |
112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47975740 |
113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46477464 |
114 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.45464148 |
115 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45204842 |
116 | Glioma_Homo sapiens_hsa05214 | 0.44709141 |
117 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43467899 |
118 | Bladder cancer_Homo sapiens_hsa05219 | 0.42750589 |
119 | Pathways in cancer_Homo sapiens_hsa05200 | 0.42684532 |
120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42629759 |
121 | Other glycan degradation_Homo sapiens_hsa00511 | 0.41708726 |
122 | Long-term potentiation_Homo sapiens_hsa04720 | 0.41348545 |
123 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40647639 |
124 | Insulin resistance_Homo sapiens_hsa04931 | 0.39336147 |
125 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.38851570 |
126 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38442414 |
127 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38429651 |
128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38219435 |
129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38098565 |
130 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37521091 |
131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37025708 |
132 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36937287 |
133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33152081 |
134 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.30125516 |
135 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28981610 |